Top Analytics Companies in Chicago, IL (185)

Strong Revenue Growth: Revenue is rising at strong double-digit rates year over year across 2025 and into mid-2026, with management increasing its outlook for 2026. Broad-based increases in originations and receivables support the top-line trajectory.

Profitability: Net income, EPS, and adjusted EBITDA are up meaningfully, and margins improved alongside stable-to-better credit metrics. This points to growth converting into stronger earnings rather than only volume expansion.

Resilient & Sustainable Growth: Multiple consecutive quarters of elevated originations and EPS growth, on top of a larger 2025 base, indicate durable momentum. Management highlights strong credit performance as a foundation for continuing expansion.

Strong Revenue Growth: Revenue scale is signaled by surpassing $500M in annual recurring revenue in July 2023, creating a high base for subsequent expansion. Company communications frame later moves as building on this milestone.

Market Expansion: Recent acquisitions—Spatial Business Systems, PDS Energy’s exchange platforms, and TGS’s A2D well log library—extend reach into utilities engineering, operational exchanges, and subsurface data. Solutions marketed across upstream, midstream, power and renewables point to a broadening footprint.

Investor Backing & Capital Strength: Blackstone agreed in August 2025 to acquire Enverus in a deal reported at $6.5B+ and later referenced deploying capital into the company in 1Q26. This indicates substantial resources and conviction to support further scaling.

Strong Revenue Growth: Revenue expanded rapidly, with FY2025 up 83% to about $1.27B and Q1/Q2 2026 up 36% and 22% year over year, respectively. Management also raised 2026 revenue guidance to approximately $1.595–$1.605B.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with Diagnostics up 34.7% in Q1 and 20% in Q2 2026 and Insights/data licensing up 36% in Q2 alongside about $200M in new licenses. Rising oncology test volumes (28–31% YoY) and accelerating MRD tests (~4,700 in Q4 2025 to ~9,000 in Q2 2026) reinforce multiple growth engines.

Profitability: The company achieved its first GAAP-profitable quarter in Q2 2026 (net income about $5.6M; Adjusted EBITDA ~$8.0M). Guidance points to further improvement in 2026, indicating progress toward sustained profitability.

Diversified Customer Base: Company materials indicate Strata now serves more than 2,300 organizations across healthcare, higher education, and financial services, with recent moves extending further into financial institutions. The Syntellis combination and the 2026 c. myers acquisition broaden exposure beyond hospitals, diversifying growth drivers.

Product Line Growth: New offerings such as StrataJazz Position Control (June 2025) and AI-driven Predictive Analytics (March 2026) expand the platform’s capabilities. These launches address labor optimization and earlier financial risk detection, signaling continued investment in the product suite.

Strategic Partnerships: A March 2025 collaboration with Snowflake is aimed at handling explosive growth in customer data needs and scaling a large comparable healthcare financial dataset. This alignment supports platform performance and data accessibility as the customer base grows.

Strong Revenue Growth: Consecutive Inc. 5000 placements in 2023 and 2024 and the company’s statement that it doubled revenue between 2019 and 2022 point to sustained top-line momentum over recent multi-year periods.

Investor Backing & Capital Strength: A February 27, 2025 growth‑equity investment from Boathouse Capital is explicitly earmarked to scale hiring, expand services and enter new markets, and potentially support M&A.

Market Expansion: Expansion moves such as acquiring Mashey, establishing an international team in Bulgaria, and enlarging its Chicago headquarters indicate a deliberate scale‑up of footprint and delivery capacity.

Investor Backing & Capital Strength: Advent International agreed on August 25, 2025 to acquire PatientPoint, with reporting at more than $1.4B, providing external validation and resources to accelerate expansion. This backing is positioned to support network growth and product innovation.

Product Line Growth: In March 2026 PatientPoint launched programmatic buying (Health Audiences) and a Consumer Health Network aimed at CPG/OTC brands, expanding how advertisers can buy and who the company serves. These additions broaden monetization beyond traditional life‑sciences sponsors.

Strong Market Position & Advantage: PatientPoint reports a nationwide footprint in 30,000+ physician offices and 125,000 providers, and in April 2026 received expanded Media Rating Council accreditation across its full digital screen network. This scale and third‑party validation bolster credibility for national buys.

Market Expansion: Headcount and footprint are described as rising to more than 15,000 employees across 40-plus offices, alongside concrete new sites in Hyderabad and a completed Chicago buildout—signals of geographic and capacity expansion. These moves indicate confidence in demand across key delivery hubs.

Innovation-Driven Growth: A dedicated Platforms & Products unit, the ZAIDYN portfolio, and AI-agent initiatives point to sustained investment in productized, AI-enabled offerings. Capability-deepening acquisitions (Digital Additive in 2024 and Torrent Consulting in 2025) further strengthen CRM and multi‑cloud life‑sciences solutions.

Strategic Partnerships: An expanded Salesforce collaboration around Agentforce and recognition as Databricks 2025 Life Sciences Partner of the Year suggest momentum in data/AI ecosystems. These alliances position the firm to capture spend where CRM, data, and AI converge in healthcare and life sciences.

Market Expansion: Lender network and consumer coverage have increased materially, with reach cited at 5 million identities and platform activity described as record in 2026. Channel momentum is evident through integrations into credit‑union cores and loan‑origination systems and active presence at credit‑union conferences.

Strategic Partnerships: Partnerships and integrations (e.g., CU*Answers, Jack Henry Symitar, Sync1, Akoya, Socure) are broadening distribution and strengthening data access. These collaborations lower adoption friction and reinforce go‑to‑market traction in the credit‑union channel.

Product Line Growth: The company is shipping new capabilities across the credit lifecycle, including lead screening, servicing alerts, and an expanded score suite with additional cashflow scores and an upgraded Early Payment Default Score in 2026. Industry program notes highlight real‑world deployments such as a credit union using the platform on all applications, indicating uptake of these offerings.

Strong Revenue Growth: Revenue is portrayed as expanding, including a 38% year-over-year increase in subscription revenue in 2024 and multiple “best quarter” records. Company communications in January 2026 cite strong 2025 results and entry into 2026 with “record momentum.”

Strong Market Position & Advantage: Market position is reinforced by leadership placements in the 2026 Gartner Magic Quadrant and the 2025–2026 IDC MarketScape. Status as the only SAP Endorsed App for pricing and repeated partner recognitions signal credible enterprise channels and competitive strength.

Customer Loyalty & Retention: Customer retention is characterized as very high, with 97.4% retention noted for 2024 and references to sustained loyalty. Narratives also point to organizations expanding usage after realizing pricing and margin gains, supporting durable growth.

Profitability: Non‑GAAP operating income and net income increased year over year in 1H 2026, and the company lifted its exit‑Q4 2026 operating margin target to about 17%. Guidance also outlines a Rule‑of‑40 target of 30% by Q4 2027, indicating continued focus on margin expansion.

Healthy Cash Flow: Non‑GAAP free cash flow reached $24.7M in Q1 2026 and remained positive in Q2, pointing to improved cash generation. These trends support ongoing investment without straining liquidity.

Innovation-Driven Growth: The launch of an AI‑powered social intelligence platform and expansion of the Trellis AI agent in 2026 are positioned to support upmarket expansion. Growth in larger ARR cohorts and rising RPO provide evidence that product advances are aligning with enterprise adoption.

Diversified Revenue Streams: The company operates multiple brands—CreditNinja (consumer lending), NinjaCard (banking plus a revolving line of credit), and EDGE (B2B underwriting/analytics)—broadening monetization beyond a single product. Public materials describe this as a multi-pronged platform spanning both consumer and enterprise lines.

Product Line Growth: Product updates such as NinjaCard’s FlexLine/FlexBanking and EDGE’s 2026 lead-screening/address-verification upgrade indicate ongoing expansion of offerings. Recent app/site updates and feature rollouts point to active development rather than a static portfolio.

Strategic Partnerships: Relationships with Republic Bank of Chicago (deposits/debit) and First Electronic Bank (lines of credit), plus integrations like Smarty and the adoption of Sparkling Logic’s SMARTS, support partner-enabled scaling. These arrangements extend program reach without requiring a bank charter.

Strong Revenue Growth: Company communications describe ARR more than tripling in 2025, marking its strongest year to date. These disclosures point to clear top‑line momentum into 2026.

Product Line Growth: Announcements highlight expanded AI functionality for healthcare in June 2026 alongside ongoing platform updates. This indicates continued investment in new capabilities and vertical depth.

Strong Hiring & Retention: Multiple senior appointments in mid‑2026, including an EVP of Technology & Operations and additional leadership roles, suggest active scaling of the executive and technical bench. References to broader team expansion reinforce organizational build‑out.

Market Expansion: Global footprint is described as 1,200–1,400 employees across 26 countries with a dozen-plus offices, a dedicated Seattle hub, and multilingual careers pages—signals of expanding operations and reach. Recent multi‑market activations (e.g., McDonald’s FIFA World Cup tie‑ins and other global launches) further indicate active presence across regions.

Strong Hiring & Retention: Careers content, open roles across locations, and August 2026 intern announcements point to ongoing hiring momentum. Repeat “Best Places to Work” recognitions in Chicago, Seattle, and Ad Age listings suggest an environment that attracts and keeps talent.

Product Line Growth: Integration of PMI Worldwide’s global merchandising unit into tms in 2023 is noted as broadening product and sourcing capabilities. This enlarged scope complements existing technology and marketing services.

Strategic Partnerships: The acquisition by Model N positions Kalderos’s 340B and gross-to-net capabilities inside a larger life-sciences revenue platform, implying broader distribution and customer access. Integration of the Truzo claims-level visibility into Model N’s suite signals strategic value and scale-up potential.

Strong Revenue Growth: Company materials state revenue more than doubled two years in a row leading into 2023, alongside expanding customers and team. These signals point to strong pre-acquisition traction that can be leveraged under Model N.

Market Expansion: 340B drug purchases reached roughly $66.3B in 2023, indicating a large and expanding market the combined offering serves. This category tailwind supports ongoing demand for discount-management and gross-to-net solutions.

Strong Market Position & Advantage: Independent analysts continue to place Qualtrics at the front of its market, with Gartner naming it a Leader in the Magic Quadrant for Voice of the Customer Platforms and positioning it highest on Ability to Execute and furthest on Completeness of Vision. This standing typically aligns with robust enterprise demand and supports commercial momentum.

Market Expansion: The company closed a $6.75 billion acquisition of Press Ganey Forsta on May 18, 2026, materially expanding its healthcare experience footprint and enlarging its data assets. Such scope increases are noted as common precursors to revenue growth and broader vertical penetration.

Innovation-Driven Growth: Qualtrics highlights rapidly expanding AI capabilities and analysis of billions of interactions annually, with usage of AI features surging and adoption widespread among large enterprise accounts. This product momentum supports upsell and cross‑sell into the installed base.

Strong Revenue Growth: Recent results show revenue up 9.6% year over year in Q2 2026 (6.8% organic; 8.2% excluding product sunsets), with 2025 up 7.5% and year‑to‑date 2026 up 10.2% on a reported basis. Growth is led by Morningstar Credit and core data/software platforms such as Morningstar Direct and PitchBook.

Profitability: Operating and adjusted operating margins expanded in Q2 2026 alongside a 29% rise in adjusted diluted EPS to $3.10, and 2025 saw increases in operating income and adjusted operating income. These gains were supported by stronger contribution from Credit and the accretive effect of the CRSP acquisition.

Healthy Cash Flow: Free cash flow and operating cash flow increased sharply in Q2 2026, with free cash flow nearly doubling year over year. This improved cash generation coincided with active buybacks and dividends.

Strong Revenue Growth: Recent disclosures point to record annual and early‑year trading results in 2025–2026, signaling sustained top‑line momentum. Company communications also highlight elevated platform activity in options and expanded client analytics, reinforcing growth.

Market Expansion: A new Amsterdam office and recent build‑outs in Tokyo and Sydney indicate active geographic scaling across Europe and Asia‑Pacific. Increased global hiring across trading, engineering, and research supports deeper regional coverage and client reach.

Strong Market Position & Advantage: Materials emphasize a leading role in U.S. equities and retail order flow alongside prominent standings in U.S. Treasuries and investment‑grade credit. Record retail options activity and investment in high‑touch coverage integrated with electronic scale suggest durable competitive advantages.

Investor Backing & Capital Strength: A $15 million commitment from Erie Street Growth Partners in 2024 is positioned to “supercharge” expansion and scale delivery, signaling strong capitalization. This fresh capital is cited alongside enterprise client references as a leading indicator of expansion.

Market Expansion: An acquisition of Dhauz in 2026 expanded the footprint across North America, Europe, and South America and lifted the combined team past 100 people. Named enterprise work (for example, with dunnhumby) and a mid‑market focus further indicate growing commercial reach.

Strong Hiring & Retention: LinkedIn signals and company updates describe a shift from a small 2024 team to an approximately 110‑person firm by 2026, with ongoing activity. Multiple senior additions (Chief Growth Officer, Head of Client Delivery, Data Engineering Lead, Managing Director) reflect investment in scaling go‑to‑market and delivery.

Strategic Partnerships: Lumen packages Prosodica Analytics in its Contact Center Intelligence, and the site highlights Five9 Accredited ISV status alongside Speechmatics and new SymTrain integrations, extending distribution and solution depth. These ties indicate active go-to-market leverage across carrier, CCaaS, and parent-ecosystem channels.

Product Line Growth: The platform has broadened beyond core analytics to Operational Intelligence, Behavioral Coaching, Conversion Optimization, Self-Service, Compliance, and Real-time Guidance, with additions like Auto-Evaluation and Engage. This expansion points to a maturing offering mapped to QA, coaching, and compliance workflows.

Innovation-Driven Growth: Materials describe sustained AI investment (e.g., GPT-3 usage since 2020), a test-and-learn culture, and new AI capabilities for automated QA and coaching. Ongoing 2026 studies, content, and integrations reinforce an innovation cadence rather than stagnation.

Innovation-Driven Growth: Regulatory momentum is evident with FDA 510(k) clearance for the eVO2peak Module and references to multiple FDA-cleared algorithms, alongside ISO 13485 and MDSAP certifications. Ongoing clinical activity and datasets (e.g., OCORO Heart Study, multi‑million hours of heart data) point to a steadily expanding product and evidence base.

Strategic Partnerships: The March 27, 2025 acquisition by Kardigan integrates Prolaio’s FDA‑cleared software, curated CV datasets, and analytics into a larger R&D platform, signaling added resources and scope. Materials indicate Prolaio continues operating independently while benefiting from Kardigan’s broader heart‑health strategy.

Strong Hiring & Retention: Hiring signals are visible through an active careers page, a stated 32 new hires in 2025, and multiple current openings across functions. Employer recognition such as “Best Places to Work 2026” and ongoing recruiting activity suggest team expansion and brand momentum.